Previous Article | Next Article ![]()
Clinical Microbiology Reviews, Oct 1996, 499-511, Vol 9, No. 4
SK Fridkin and WR Jarvis
This paper briefly reviews the current knowledge of the epidemiology and
modes of transmission of nosocomial fungal infections and some of the
therapeutic options for treating these diseases. In the mid-1980s, many
institutions reported that fungi were common pathogens in nosocomial
infections. Most, if not all, hospitals care for patients at risk for
nosocomial fungal infections. The proportion in all nosocomial infections
reportedly caused by Candida spp. increased from 2% in 1980 to 5% in 1986
to 1989. Numerous studies have identified common risk factors for acquiring
these infections, most of which are very common among hospitalized
patients; some factors act primarily by inducing immunosuppression (e.g.,
corticosteroids, chemotherapy, malnutrition, malignancy, and neutropenia),
while others primarily provide a route of infection (e.g., extensive burns,
indwelling catheter), and some act in combination. Non-albicans Candida
spp., including fluconazole-resistant C. krusei and Torulopsis (C.)
glabrata, have become more common pathogens. Newer molecular typing
techniques can assist in the determination of a common source of infection
caused by several fungal pathogens. Continued epidemiologic and laboratory
research is needed to better characterize these pathogens and allow for
improved diagnostic and therapeutic strategies.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
Epidemiology of nosocomial fungal infections
Section of Infectious Disease, Rush Medical College/Rush-Presbyterian- St. Luke's Medical Center, Chicago, Illinois 60612, USA.
This article has been cited by other articles:
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»